Cadre (CDRE) Competitors $31.27 -0.30 (-0.95%) Closing price 03:58 PM EasternExtended Trading$31.32 +0.05 (+0.16%) As of 04:43 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock CDRE vs. INSP, NARI, PRCT, IRTC, NVST, TMDX, SLNO, ENOV, LIVN, and NVCRShould you be buying Cadre stock or one of its competitors? The main competitors of Cadre include Inspire Medical Systems (INSP), Inari Medical (NARI), PROCEPT BioRobotics (PRCT), iRhythm Technologies (IRTC), Envista (NVST), TransMedics Group (TMDX), Soleno Therapeutics (SLNO), Enovis (ENOV), LivaNova (LIVN), and NovoCure (NVCR). These companies are all part of the "medical equipment" industry. Cadre vs. Inspire Medical Systems Inari Medical PROCEPT BioRobotics iRhythm Technologies Envista TransMedics Group Soleno Therapeutics Enovis LivaNova NovoCure Inspire Medical Systems (NYSE:INSP) and Cadre (NYSE:CDRE) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their community ranking, risk, analyst recommendations, earnings, valuation, institutional ownership, dividends, media sentiment and profitability. Is INSP or CDRE more profitable? Inspire Medical Systems has a net margin of 6.67% compared to Cadre's net margin of 6.34%. Cadre's return on equity of 12.88% beat Inspire Medical Systems' return on equity.Company Net Margins Return on Equity Return on Assets Inspire Medical Systems6.67% 8.19% 7.09% Cadre 6.34%12.88%6.06% Which has higher valuation and earnings, INSP or CDRE? Inspire Medical Systems has higher revenue and earnings than Cadre. Cadre is trading at a lower price-to-earnings ratio than Inspire Medical Systems, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioInspire Medical Systems$802.80M6.13$53.51M$1.7395.60Cadre$567.56M2.24$38.64M$0.9034.74 Which has more volatility & risk, INSP or CDRE? Inspire Medical Systems has a beta of 1.48, suggesting that its stock price is 48% more volatile than the S&P 500. Comparatively, Cadre has a beta of 1.3, suggesting that its stock price is 30% more volatile than the S&P 500. Does the MarketBeat Community believe in INSP or CDRE? Inspire Medical Systems received 177 more outperform votes than Cadre when rated by MarketBeat users. Likewise, 61.66% of users gave Inspire Medical Systems an outperform vote while only 55.17% of users gave Cadre an outperform vote. CompanyUnderperformOutperformInspire Medical SystemsOutperform Votes19361.66% Underperform Votes12038.34% CadreOutperform Votes1655.17% Underperform Votes1344.83% Do analysts rate INSP or CDRE? Inspire Medical Systems currently has a consensus price target of $228.82, indicating a potential upside of 38.36%. Cadre has a consensus price target of $37.00, indicating a potential upside of 18.32%. Given Inspire Medical Systems' higher possible upside, equities research analysts plainly believe Inspire Medical Systems is more favorable than Cadre.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Inspire Medical Systems 0 Sell rating(s) 3 Hold rating(s) 8 Buy rating(s) 0 Strong Buy rating(s) 2.73Cadre 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Does the media favor INSP or CDRE? In the previous week, Cadre had 9 more articles in the media than Inspire Medical Systems. MarketBeat recorded 11 mentions for Cadre and 2 mentions for Inspire Medical Systems. Inspire Medical Systems' average media sentiment score of 1.51 beat Cadre's score of 0.66 indicating that Inspire Medical Systems is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Inspire Medical Systems 1 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Cadre 6 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Do insiders and institutionals have more ownership in INSP or CDRE? 94.9% of Inspire Medical Systems shares are owned by institutional investors. Comparatively, 44.0% of Cadre shares are owned by institutional investors. 4.1% of Inspire Medical Systems shares are owned by insiders. Comparatively, 37.0% of Cadre shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth. SummaryInspire Medical Systems beats Cadre on 14 of the 18 factors compared between the two stocks. Remove Ads Get Cadre News Delivered to You Automatically Sign up to receive the latest news and ratings for CDRE and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CDRE vs. The Competition Export to ExcelMetricCadreSurgical appliances & supplies IndustryIndustrials SectorNYSE ExchangeMarket Cap$1.27B$9.14B$7.08B$19.75BDividend Yield1.18%1.41%3.54%3.75%P/E Ratio37.6717.6821.0334.05Price / Sales2.2470.0574.1028.57Price / Cash22.8919.6726.8317.54Price / Book5.965.653.744.63Net Income$38.64M$284.66M$793.45M$1.02B7 Day Performance-3.48%2.33%0.07%1.12%1 Month Performance-6.38%-1.93%0.15%-1.07%1 Year Performance-9.88%-15.84%28.79%7.08% Cadre Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CDRECadre3.1257 of 5 stars$31.27-1.0%$37.00+18.3%-9.0%$1.27B$567.56M37.672,240Insider TradeINSPInspire Medical Systems4.7036 of 5 stars$170.89+3.6%$228.82+33.9%-13.4%$5.09B$802.80M98.781,246Positive NewsNARIInari Medical0.936 of 5 stars$79.97flat$68.00-15.0%N/A$4.68B$493.63M-59.24800PRCTPROCEPT BioRobotics3.0601 of 5 stars$60.90+4.8%$94.29+54.8%+27.8%$3.34B$224.50M-31.23430News CoverageIRTCiRhythm Technologies1.5315 of 5 stars$105.86+1.3%$119.73+13.1%-2.3%$3.33B$591.84M-29.081,790Positive NewsGap UpNVSTEnvista4.1292 of 5 stars$17.51+5.1%$20.18+15.3%-17.9%$3.01B$2.51B-2.7012,700TMDXTransMedics Group3.051 of 5 stars$71.47+3.5%$122.70+71.7%+0.9%$2.41B$441.54M76.03210SLNOSoleno Therapeutics4.4317 of 5 stars$50.14+2.1%$71.20+42.0%+19.4%$2.30BN/A-15.1030ENOVEnovis2.8272 of 5 stars$40.01+2.4%$58.50+46.2%-33.5%$2.28B$2.11B-18.276,550Positive NewsLIVNLivaNova4.2276 of 5 stars$40.37+2.3%$61.17+51.5%-27.9%$2.19B$1.25B96.122,900Positive NewsNVCRNovoCure3.6151 of 5 stars$19.78+2.3%$35.80+81.0%+49.7%$2.17B$605.22M-14.131,320Positive News Remove Ads Related Companies and Tools Related Companies INSP Alternatives NARI Alternatives PRCT Alternatives IRTC Alternatives NVST Alternatives TMDX Alternatives SLNO Alternatives ENOV Alternatives LIVN Alternatives NVCR Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:CDRE) was last updated on 3/25/2025 by MarketBeat.com Staff From Our PartnersYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredDOGE officially begins retirement transformationElon Musk's Department of Government Efficiency ("DOGE") just announced the first-ever "fully digital retireme...Altimetry | Sponsored“Amazon Coin” set to outperform BitcoinChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredEx CIA predicts 40% “double crash” – April 11The scientists here don’t study deadly viruses… directed energy weapons… or even weather control technology… ...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cadre Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cadre With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.